The information on this page is intended for journalists, press and media. Click YES to get to the newsroom. If you click NO you will come back to Mynewsdesk.com.
NNIT completes successful collaboration with a Top 20 Biopharma pioneer in transitioning to a new Electronic Data Capture (EDC) platform for their clinical trials.
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
As NNIT expands its presence in the United States, particularly with the anticipated integration of Excellis Health Solutions (Excellis), Greg Cathcart, Head of Excellis, will assume the lead role of Senior Vice President to accelerate growth and advance the market position in the US.
Implementing an electronic Trial Master File (eTMF) system can revolutionize the way clinical trials are managed. However, as Michael Agard, Director of Clinical Consulting at NNIT, points out, the true value of eTMF lies in post-implementation management.
We are proud to share that NNIT has once again received the highest Veeva partner acknowledgement and certification as Premiere Services Partner – Development Cloud.
The backbone of every clinical trial is undergoing an inevitable digital revolution. Klaudia Markowski, Senior Business Consultant at NNIT, explains why the appropriate time to implement an electronic Trial Master File (eTMF) might be sooner than you think.
For the past many years, corporate sustainability work and reporting have been more or less ungoverned and unaudited (under the Non-Financial Reporting Directive). Soon, with EU’s Corporate Sustainability Reporting Directive (CSRD) coming into effect in January 2024, the scope of requirements will be significantly extended, impacting up to 50,000 European companies.
Following an audit of our Environmental Management System, carried out by ISO certifiers DNV earlier this month, the NNIT headquarters formally received its ISO 14001 certification on February 8.
Gens & Associates ranks NNIT as a global leader in Regulatory Information Management system implementations
NNIT has evolved quite dramatically over the years, from a small independent IT consultancy born out of Novo Nordisk to a publicly listed company and now an international group of companies in its own right. This article is the second in a series looking at the individual NNIT Group Companies.
When talking about counterfeiting, most of us think about major consumer brands but, unfortunately, counterfeiting is also a major and growing problem within the life sciences industry – and to make matters worse, nobody knows exactly how big the problem is.
When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.
To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.
Please note that our Terms of Use apply to all use of our services.
You can withdraw your consent at any time by unsubscribing or deleting your account.
Email sent to __email__. Click the link there to follow NNIT News.